|
|
|
BioTrove and Schering-Plough Research Institute Expand RapidFire™ Lead Discovery Collaboration
Woburn, MA, December 06, 2005
Marine Institute, BioTrove, and NUI Cork Initiate Novel Genetic Fingerprinting Study on Atlantic Salmon
Woburn, MA, December 05, 2005
BioTrove and Sirtris Pharmaceuticals Expand RapidFire™ High Throughput Screening Relationship
Woburn, MA, November 09, 2005
BioTrove Screens One Million Samples in 12 Months Using Mass Spectrometry
Woburn, MA, March 16, 2005
BioTrove, Inc. Licenses Genomics Application from Stanford University for Nanotiter Plates
Woburn, MA, July 15, 2004
BioTrove, Inc. Appoints Michael Olex as Vice President of Manufacturing
Woburn, MA, May 6, 2004
BioTrove, Inc. Appoints Alan Carter as Vice President of Worldwide Sales
Woburn, MA, April 26, 2004
BioTrove, Inc. Completed a $13.7 Million Round of Financing with the Closing of a Second Traunch of $2.8 Million
Woburn, MA, April 15, 2004
BioTrove Launches SNP Genotyping Capability – The First Application of the Living Chip™ Nano-Fluidics Technology Platform
Woburn, MA, March 25, 2004
BioTrove’s Momentum Signs First Contract with Large Pharmaceutical Customer
Woburn, MA, March 22, 2004
BioTrove, Inc. Secures $10.9 Million to Continue the Development and Commericalization of Novel Nano-Scale Drug Discovery Solutions
Woburn, MA, January 29, 2004
BioTrove, Inc. Names Robert H. Ellis as President and Chief Executive Officer
Woburn, MA, October 20, 2003
BioTrove, Inc. Purchases Through-Hole Array Intellectual Property Portfolio from Genencor International Inc
Woburn, MA, September 26, 2003
BioTrove, Inc. Launches Momentum™ Technology—Ultra High Throughput Mass Spectrometry System for Functional Assay Development
Woburn, MA, August 11, 2003
BioTrove Names Robert H. Ellis as Chief Operating Officer
Woburn, MA, May 30, 2003
BioTrove, Inc. Relocates Corporate Headquarters to Woburn, Massachusetts
Woburn, MA, April 1, 2003
BioTrove Raises $5.25 Million in Venture Financing
Cambridge, MA, November 6, 2002
BioTrove Announces Completion of One Million
Cell Assays with the Living Chip™ Technology
Cambridge, MA, July 30, 2002
BioTrove Announces Issuance of First Patent
for the Living Chip™ Massively Parallel Drug Discovery Technology
Cambridge, MA, June 3, 2002
BioTrove Announces Issuance of Patent for
Nanoliter-Volume Assay Platform
Cambridge, MA, January 24, 2002
BioTrove Announces Advanced Technology
Program Award from N.I.S.T. for Massively Parallel Screening
Cambridge, MA, June 20, 2001
BioTrove, Inc. Announces Collaborative
Agreement with Pfizer, Inc
Cambridge, MA, January 12, 2001
|
 |
|
|
|
